Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.
Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 3, 2022 | Series A | $10M | 1 |
|
— | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 3, 2017
![]() |
Series Unknown | $2.50M | Analytics | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
|
Yes | Series A |